Adrenal Cortical Carcinoma
10 clinical trials · Condition
◉ Watch Adrenal Cortical Carcinoma
| Record | Firm | Date |
|---|---|---|
| Development of Clinical Evidence for Optimal Management of Adrenal Diseases Based on Real-World Data (NCT06229405) | Seoul National University Hospital | 2022-05-10 |
| Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors (NCT02867592) | National Cancer Institute (NCI) | 2017-05-18 |
| Nivolumab and Ipilimumab in Treating Patients With Rare Tumors (NCT02834013) | National Cancer Institute (NCI) | 2017-01-30 |
| A Study of Combination Chemotherapy and Surgical Resection in the Treatment of Adrenocortical Carcinoma: Continuous Infusion Doxorubicin, Vincristine and Etoposide With Daily Mitotane Before and After Surgical Resection (NCT00001339) | National Cancer Institute (NCI) | 1993-08-01 |
Track Adrenal Cortical Carcinoma automatically
Every clearance here is in the API, with alerts when new ones post.